跳至主要内容
临床试验/NL-OMON47887
NL-OMON47887已完成不适用

Translating neuroimaging findings from research into clinical practice (PSYSCAN): Clinical High Risk - PSYSCAN - UHR

Institute of Psychiatry, King's College, London0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 99(—)

入选标准

  • * 16-40 years old
  • * Written informed consent of subjects aged 18 to 40 years
  • * Written informed consent of parents and/or legal guardians for subjects aged
  • 16 or 17, in
  • addition to assent from the minor subject, following local laws and regulations
  • Participants at high risk of psychosis will be evaluated using a quantitative
  • clinical tool that
  • * Inclusion into one of three groups as assessed by the Comprehensive
  • Assessment of At-Risk Mental States (CAARMS version 2006):
  • i) vulnerability group,
  • ii) attenuated psychosis group,
  • iii) brief intermittent psychosis symptoms group.

排除标准

  • * Any previous neurosurgery or neurological disorder, including epilepsy
  • * History of head injury resulting in unconsciousness lasting at least 1 hour
  • * Pregnancy
  • * Any contraindications for MRI
  • * Refusing to have blood drawn and/or MRI performed
  • * Subject is unable to fully comprehend the purpose of the study or make a
  • decision whether or not to participate
  • * Estimate of IQ < 70
  • * Antipsychotic medication for > 30 days (cumulative number of days) in the 3
  • before the baseline assessments (including self-ratings and screening
  • assessments), at
  • doses that would be adequate for treating a first episode of psychosis (i.e.
  • excludes very
  • * Any past episode of frank psychosis lasting > 7 days

研究者

发起方
Institute of Psychiatry, King's College, London

相似试验